Last updated: 2024, May 30 08:41:59
Total pages: 712 www.otavachemicals.com Homepage

• https://www.otavachemicals.com/17 pages [+695 in 11 subfolders]
• • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • Contact info
    OTAVAchemicals contact information http://www.otavachemicals.com
  • Send us your structure
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • Design your target-focused library
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals Ligand-Based Approach to Design Targeted Libraries
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals Receptor-Based Approach to Design Targeted Libraries
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • Check your ordering status
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • Bayesian and pharmacophore modeling: Description of the algorithm
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • OTAVAchemicals, Ltd - synthetic organic compounds for research and drug discovery
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • List of Molecular Targets
    Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
• • products/15 pages [+501 in 6 subfolders]
  • • Chemical Building Blocks
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Fragment Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Compound Libraries for HTS
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Targeted Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • 12 Billion Novel Molecules: CHEMriya - OTAVA's On-Demand Chemical Space
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Biochemicals
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Screening Compounds for Agrochemical Discovery
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Kilo scale compounds
      In-house stock collection contains about 70,000 compounds. All compounds have undergone quality control by 1H-NMR to confirm their chemical structure. The purity is at the least 90%.
    • Quaternary Ammonium Salts
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Unsymmetrical Diaryliodonium Salts
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • chemical-building-blocks?format=feed&type=rss
    • fragment-libraries?format=feed&type=rss
    • compound-libraries-for-hts?format=feed&type=rss
    • biochemicals?format=feed&type=rss
    • screening-compounds-for-agrochemical-discovery?format=feed&type=rss
  • • targeted-libraries-and-focused-libraries/17 pages [+12 in 2 subfolders]
    • • All Targeted Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • SARS-CoV-2 Targeted Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • iPPI Focused Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Disease-Based Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Epigenetic Targets
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Peptidomimetic Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Glycomimetic Focused Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Protein Kinase focused libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Protease Targeted Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • GPCR Targeted Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Nuclear Receptors
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Ion Channel Targeted Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • RNA Targeted Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • General Activitiy Focused Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Other Focused Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • sars-cov-2?format=feed&type=rss
      • disease-based-libraries?format=feed&type=rss
    • • sars-cov-2/8 pages
      • • SARS-CoV-2 RNA-dependent RNA Polymerase Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • SARS-CoV-2 Main Protease Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Machine Learning SARS Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • SARS-CoV-2 NSP16 Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • SARS-CoV-2 Papain-like Protease Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • SARS-CoV-2 Helicase Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • SARS-CoV-2 Endoribonuclease Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • SARS-CoV-2 Nonstructural Protein 14 (NSP14) Targeted Library
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • disease-based-libraries/4 pages
      • • Alzheimer's Disease Targeted Libraries
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Diabetes Targeted Libraries
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Cancer Targeted Libraries
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Hepatitis C Virus Targeted Libraries
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • chemical-building-blocks/2 pages [+4 in 1 subfolder]
    • • Virtual Chemical Building Blocks
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Chemical Building Blocks for Prompt Delivery
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • • chemical-building-blocks-for-prompt-delivery/2 pages [+2 in 1 subfolder]
      • • Sample examples
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • sample-examples?format=feed&type=rss
      • • sample-examples/2 pages
        • • CAS Registry Number: 17380-62-0
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • CAS Registry Number: 5296-90-2
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • fragment-libraries/7 pages
    • • General Fragments Library
        The OTAVAchemicals�s Fragments library has been designed based upon the commonly accepted Rule-of-Three and other physicochemical and structural properties. The central purpose of this specially designed Fragment Library is to provide fragments that will bind to the binding site of any target and will also provide suitable starting points for drug discovery.
      • Solubility Fragment Library
        The OTAVAchemicals�s Fragments library has been designed based upon the commonly accepted Rule-of-Three and other physicochemical and structural properties. The central purpose of this specially designed Fragment Library is to provide fragments that will bind to the binding site of any target and will also provide suitable starting points for drug discovery.
      • Fluorine Fragment Library
        The OTAVAchemicals�s Fragments library has been designed based upon the commonly accepted Rule-of-Three and other physicochemical and structural properties. The central purpose of this specially designed Fragment Library is to provide fragments that will bind to the binding site of any target and will also provide suitable starting points for drug discovery.
      • Chelator Fragment Library
        The OTAVAchemicals�s Fragments library has been designed based upon the commonly accepted Rule-of-Three and other physicochemical and structural properties. The central purpose of this specially designed Fragment Library is to provide fragments that will bind to the binding site of any target and will also provide suitable starting points for drug discovery.
      • Halogen-Enriched Fragments
        The OTAVAchemicals�s Fragments library has been designed based upon the commonly accepted Rule-of-Three and other physicochemical and structural properties. The central purpose of this specially designed Fragment Library is to provide fragments that will bind to the binding site of any target and will also provide suitable starting points for drug discovery.
      • General Fragments Library
        The OTAVAchemicals�s Fragments library has been designed based upon the commonly accepted Rule-of-Three and other physicochemical and structural properties. The central purpose of this specially designed Fragment Library is to provide fragments that will bind to the binding site of any target and will also provide suitable starting points for drug discovery.
      • General Fragments Library
        The OTAVAchemicals�s Fragments library has been designed based upon the commonly accepted Rule-of-Three and other physicochemical and structural properties. The central purpose of this specially designed Fragment Library is to provide fragments that will bind to the binding site of any target and will also provide suitable starting points for drug discovery.
    • compound-libraries-for-hts/10 pages
    • • NEW! Scaffolds
        Custom synthesis on the base of rare scaffolds. The scaffold database were prepared using comparative analysis of world-wide suppliers of compound libraries. This is your opportunity to get novel compounds for screening purposes.
      • Diversity Libraries
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Screening Compounds For Prompt Delivery
        In-house compounds library contains about 70,000 compounds. All compounds have undergone quality control by 1H-NMR to confirm their chemical structure. The purity is at the least 90%.
      • Phenotypic Screening Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Tangible Screening Compounds
        About 65,000 compounds are available from our outside suppliers. The greatest advantage of your selecting from these database is a unique access to historical compound colections of individual chemists.
      • Drug-Like Green collection
        The Green Collection compound library (more than 37,000 compounds total) was prepared on the basis of In-house Stock library and pre-formatted by Lipinsky “rules of five”
      • Lead-like library
        In-house stock collection contains about 70,000 compounds. All compounds have undergone quality control by 1H-NMR to confirm their chemical structure. The purity is at the least 90%.
      • CNS Library
        In-house stock collection contains about 70,000 compounds. All compounds have undergone quality control by 1H-NMR to confirm their chemical structure. The purity is at the least 90%.
      • Natural Product-Like Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Screening Compounds For Prompt Delivery
        In-house compounds library contains about 70,000 compounds. All compounds have undergone quality control by 1H-NMR to confirm their chemical structure. The purity is at the least 90%.
    • biochemicals/130 pages [+315 in 5 subfolders]
    • • Protein Kinase Inhibitors
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Cell Signaling
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Stem Cell Research
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Metabolism / Metabolite
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Various inhibitors and other biologically active compounds
        OTAVAchemicals offers a number of inhibitors, activators and other biologically active compounds modulating activity of distinct targets. These compounds are available in milligram and gram quantities. Custom and bulk quotes are also available.
      • protein-kinase-inhibitors?format=feed&type=rss
      • cell-signaling?format=feed&type=rss
      • stem-cell-research?format=feed&type=rss
      • metabolism-metabolite?format=feed&type=rss
      • Casein kinase inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • New CK2 inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • CK2 inhibitor NSC 210902
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Inhibitor of CK2 kinase
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • CK2 inhibitor (IQA, CGP029482)
        CK2 inhibitor 5,6-Dihydro-5-oxo-indolo[1,2-a]quinazoline-7-acetic acid (IQA; CGP029482)
      • EGFR-kinase inhibitor
        N-(3-Bromophenyl)-6,7-dimethoxy-4-quinazolinamine hydrochloride (AG 1517; NSC 669364; PD 153035; SU 5271; WHI-P79) EGFR-kinase inhibitor
      • HDAC, EGFR, and HER2 Inhibitor
        HDAC, EGFR, and HER2 Inhibitor 7-[4-(3-Chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-heptanoic acid hydroxyamide (1012054-55-5)
      • Antagonist of the VEGFR and the EGFR
        Antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR) N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine (Vandetanib; ZD6474; Zactima)
      • Inhibitor of VEGF receptor tyrosine kinases
        Inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases 4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline (AZD2171; Cediranib)
      • VEGFR-2 inhibitor
        VEGFR-2 inhibitor 4-((2-((4-Chloro-3-((((2S)-1-methyl-2-pyrrolidinyl)methyl)oxy)-phenyl)amino)-1,3-benzoxazol-5-yl)oxy)-N-methyl-2-pyridinecarboxamide
      • PDGFR, VEGFR and FGFR inhibitor
        5-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid (NSC 702827; SU 6668; TSU 68) - PDGFR, VEGFR and FGFR inhibitor
      • Inhibitor of the VEGFR-2 and FGFR1 kinases
        Inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases 3-[(4-Bromo-2,6-difluorophenyl)methoxy]-5-[[[[4-(1-pyrrolidinyl)butyl]amino]carbonyl]amino]-4-isothiazolecarboxamide (CP-547632)
      • Dual VEGFR-2 and tubulin inhibitor
        Dual VEGFR-2 and tubulin inhibitor (2,3-Dihydro-benzo[1,4]dioxin-6-yl)-(5-{2-[(pyridin-4-ylmethyl)-amino]-phenyl}-[1,3,4]oxadiazol-2-yl)-amine (830333-53-4)
      • Inhibitor of basic Fibroblast Growth Factor (bFGF)
        PD166866 (N-[2-Amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-urea) -Inhibitor of basic Fibroblast Growth Factor (bFGF)
      • Selective HDAC1 and HDAC2 Inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • HDAC1 & 2 Inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Histone deacetylase HDAC1 inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Histone Deacetylase Inhibitor VI
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Janus Kinase 3 Inhibitor
        4-[(6,7-Dimethoxy-4-quinazolinyl)amino]-phenol (4-(4'-Hydroxyphenyl)amino-6,7-dimethoxyquinazoline; JANEX-1; WHI-P131) Janus kinase 3 inhibitor
      • JAK2 Inhibitor
        JAK2 Inhibitor (2E)-3-(6-Bromo-2-pyridinyl)-2-cyano-N-[(1S)-1-phenylethyl]-2-propenamide (WP1066)
      • Selective inhibitor of c-Jun N-terminal kinase
        Selective inhibitor of c-Jun N-terminal kinase 5-[(5-Nitro-2-thiazolyl)thio]-1,3,4-thiadiazol-2-amine (SU 3327)
      • JNK inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Cyclin-dependent Kinase (CDK) Inhibitor
        3-[(6,7-Dimethoxy-4-quinazolinyl)amino]-phenol (Janex 3; WHI-P180) Cyclin-dependent Kinase (CDK) Inhibitor
      • Inhibitor of the Hedgehog Signalling Pathway II
        JK 184 (N-(4-Ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-thiazolamine) - Inhibitor of the Hedgehog Signalling Pathway
      • Inhibitor of the Hedgehog Signalling Pathway
        N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[[3-(4-fluorophenyl)-3,4-dihydro-4-oxo-2-quinazolinyl]methyl]-urea - Inhibitor of the Hedgehog Signalling Pathway
      • An inhibitor of the Hh signaling pathway
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • An inhibitor of the Hh signaling pathway
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • SIRT1 activator
        1-(4-Fluorophenyl)-3-(phenylsulfonyl)-1H-pyrrolo[2,3-b]quinoxalin-2-amine SIRT1 activator
      • AGK-2 - SIRT2 Inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Inhibitor of the deacetylase SIRT1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • SIRT1/2 Inhibitor IV, Cambinol
        NSC-112546 SIRT1/2 Inhibitor IV, Cambinol, 5-(2-Hydroxy-naphthalen-1-ylmethyl)-6-phenyl-2-thioxo-2,3-dihydro-1H-pyrimidin-4-one
      • Mitogen-activated protein kinase 1/2 inhibitor
        ARRY 142886; ARRY-142886; AZD 6244 Mitogen-activated protein kinase 1/2 inhibitor
      • MEK1 inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Mitogenic extracellular kinase 1/2 (MEK1/2) inhibitor
        PD-0325901 Mitogenic extracellular kinase 1/2 (MEK1/2) inhibitor
      • Inhibitor of Phenylethanolamine N-Methyl-Transferase
        Inhibitor of Phenylethanolamine N-Methyl-Transferase 1,2,3,4-Tetrahydro-7-isoquinolinesulfonamide (SK&F 29661)
      • Cdk4/6 Inhibitor IV
        CINK4 (trans-4-[[6-(Ethylamino)-2-[[1-(phenylmethyl)-1H-indol-5-yl]amino]-4-pyrimidinyl]amino]-cyclohexanol) - Cdk4/6 Inhibitor IV
      • CDK9 Inhibitor II
        CAN508 (4-(3,5-Diamino-1H-pyrazol-4-ylazo)-phenol) CDK9 Inhibitor II
      • Cdk4 Inhibitor
        2-Bromo-12,13-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione - Cdk4 Inhibitor
      • Cdk4 Inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Cdk4 Inhibitor
        Arcyriaflavin A (12,13-Dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione)- Cdk4 Inhibitor
      • Selective CDK2 and CDK9 inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Voltage-independent, selective CFTR chloride channel blocker
        4-[[4-Oxo-2-thioxo-3-[3-(trifluoromethyl)phenyl]-5-thiazolidinylidene]methyl]-benzoic acid (CFTRinh-172) - Voltage-independent, selective CFTR chloride channel blocker
      • Inhibitor of the deubiquitinating activity of human USP14
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Polo-like kinase 1 (PLK1) inhibitor
        5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[4-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarboxamide - PLK1 inhibitor with pIC ~6.9
      • Inhibitor of IKK kinase
        Potent and selective inhibitor of IKK- kinase that selectively inhibits IKK-ε with an IC50 value of 40 nM and is essentially inactive at IKK-α and IKK-β
      • Inhibitor of cGMP-specific phosphodiesterase
        Inhibitor of cGMP-specific phosphodiesterase N-(1,3-Benzodioxol-5-ylmethyl)-6-methoxy-4-quinazolinamine
      • Benzenesulfonanilide-type cyclooxygenase-1-selective inhibitor
        4-Amino-N-(4-chlorophenyl)-N-methyl-benzenesulfon - benzenesulfonanilide-type cyclooxygenase-1-selective inhibitor
      • Hypoxia Inducible Factor-1α Inhibitor
        4-Hydroxy-3-[[2-(4-tricyclo[3.3.1.13,7]dec-1-ylphenoxy)acetyl]amino]-benzoic acid methyl ester - Hypoxia Inducible Factor-1α Inhibitor
      • BRAF Inhibitor
        BRAF Inhibitor N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[4-[(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-7-yl)oxy]-2-(methylthio)phenyl]-urea
      • Human 20α-hydroxysteroid dehydrogenase (AKR1C1) inhibitor
        Human 20α-hydroxysteroid dehydrogenase (AKR1C1) inhibitor 3-Bromo-5-phenylsalicylic acid (NSC109116)
      • Ilomastat; Galardin
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • An inhibitor of Nek2/Hec1 exhibits
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Inhibitor of Nek2-Hec1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Inhibitor of Nek2Hec1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Thiazovivin
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • PI4-kinase inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • PI3K Inhibitor
        PI3K Inhibitor N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide (PIK-90)
      • Inhibitor of PI3K
        Inhibitor of PI3 kinase 8-(4-Fluoro-2-methylphenoxy)-2-(4-morpholinyl)-4(1H)-quinolinone (TGX155)
      • Inhibitor of the p110 isoform of PI3 kinase
        IC87114 (2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone) - selective inhibitor of the p110 isoform of PI3 kinase
      • Inhibitor of PI3 kinase
        Inhibitor of PI3 kinase 8-(2-Methylphenoxy)-2-(4-morpholinyl)-4(1H)-quinolinone (TGX115)
      • Dual PI3K-α and mTOR inhibitor
        Dual PI3K-α and mTOR inhibitor 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea (PKI-587, PF-05212384, 1197160-78-3)
      • Selective DNA-PK and mTOR inhibitor
        2-(4-Morpholinyl)-4H-Pyrimido[2,1-a]isoquinolin-4-one (Compound 401) Selective DNA-PK and mTOR inhibitor
      • PDK1 Inhibitor BX-795
        BX-795, BX-912, and BX-320: potent PDK1 inhibitors with IC50 = 11-30 nM
      • BX-320 - PDK1 inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • PDK1 Inhibitor
        PDK1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU03012)
      • BX-912 - PDK1 inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • GSK-3ß inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • GSK-3ß inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Glycogen synthase kinase-3 (GSK-3) inhibitor
        TWS119 (3-[[6-(3-aminophenyl)-1H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]-phenol ) - glycogen synthase kinase-3 (GSK-3) inhibitor
      • BIP-135
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • GSK4716
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • GPR40 antagonist
        GPR40 antagonist 1-(4-Ethoxycarbonylphenyl)-2-(4-fluorobenzylthio)-5-(2-ethoxy-5-pyrimidinylmethyl)-4-pyrimidinone (GW1100)
      • Antagonist of NMDA receptor
        Antagonist of NMDA receptor 1,2-Dihydro-2-naphthalenamine hydrochloride
      • Partial dopamine D2 agonist; 5-HT1A agonist
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Histamine H4 receptor agonist
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Potent and positive allosteric mGlu4 agonist
        Potent and positive allosteric mGlu4 agonist (±)-cis-2-{[(3,5-dichlorophenyl)amino]carbonyl}cyclohexanecarboxylic acid ((1R,2S)-rel-2-[[(3,5-dichlorophenyl)amino]carbonyl]-cyclohexanecarboxylic acid; VU0155041)
      • Autophagy Inducer
        STF-62247 (N-(3-Methylphenyl)-4-(4-pyridinyl)-2-thiazolamine) - Autophagy Inducer, selectively induces cell death in VHL-deficient cells
      • ML 221
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • CYR-101 (MIN-101, MT-210)
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • S1RA (E-52862)
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • eIF4E/eIF4G Interaction Inhibitor
        4EGI-1 (2-((4-(3,4-Dichlorophenyl)-thiazol-2-ylhydrazono)-3-(2-nitrophenyl))propionic acid) eIF4E/eIF4G Interaction Inhibitor
      • eEF-2 Kinase Inhibitor
        NH125 (1-Hexadecyl-2-methyl-3-(phenylmethyl)-1H-imidazolium iodide)- eEF-2 Kinase Inhibitor
      • Stem Cell Reagent; Wnt Pathway Activator III
        Stem Cell Reagent; Wnt Pathway Activator III 2-[(4-Acetylphenyl)azo]-2-(3,4-dihydro-3,3-dimethyl-1(2H)-isoquinolinylidene)-acetamide (IQ-1)
      • STAT3 Inhibitor VI
        2-Hydroxy-4-[[[[(4-methylphenyl)sulfonyl]oxy]acetyl]amino]-benzoic acid (NSC 74859; S3I-201) STAT3 Inhibitor VI
      • AMPK activator
        AMPK activator 6,7-Dihydro-4-hydroxy-3-(2'-hydroxy[1,1'-biphenyl]-4-yl)-6-oxo-thieno[2,3-b]pyridine-5-carbonitrile (A-769662)
      • Antitumor agent activating procaspase-3 to caspase-3
        PAC-1 is the first small molecule known to directly activate procaspase-3 to caspase-3, a transformation that allows induction of apoptosis even in cells that have defective apoptotic machinery
      • p53 activator
        p53 activator N-[[[4-(Acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)-benzamide (Tenovin 1)
      • cFMS Receptor Inhibitor IV
        5-Cyano-N-(2,5-di-1-piperidinylphenyl)-2-furancarboxamide - cFMS Receptor Tyrosine Kinase Inhibitor
      • Cardial depressant (antiarrhythmic)
        6-[(3,4,5-Trimethoxybenzoyl)amino]-hexanoic acid - cardial depressant (antiarrhythmic)
      • Spleen Tyrosine kinase (Syk) inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Syk kinase inhibitor
        Syk kinase inhibitor 3,3'-[(5-Fluoro-2,4-pyrimidinediyl)diimino]bis-phenol (R112)
      • Inhibitor of Syk kinase
        Syk kinase inhibitor 2-[(2-Aminoethyl)amino]-4-[[3-(trifluoromethyl)phenyl]amino]-5-pyrimidinecarboxamide
      • Sephin 1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • IOX1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • WS204188
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Antimalarial agents targeting PfCCT
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Inhibitor of the ATP-binding cassette
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Aloesone
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • NSC 97072, PCC
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Selective ß-arrestin/ß2-adaptin inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Inhibitor PKD kinase
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • ML 133 hydrochloride
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • MLKL Inhibitor, Necrosulfonamide
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Inhibitors of SARS-CoV 3CLpro
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • A-867744
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • I3MT-3; HMPSNE
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Salubrinal
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Cycloguanil (hydrochloride)
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Nifetepimine
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • G6PDi-1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • CaMKII-IN-1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • HBF-0259
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • CCT036477
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • BACE-1 inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Spautin-1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • FCE 22178, rolafagrel
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Cicletanine, tenstaten
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • SMER28
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Potent and selective ALK5 inhibitors over p38MAP kinase
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • CID 9998128
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Antimalarial agents targeting PfCCT
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • • protein-kinase-inhibitors/39 pages [+147 in 19 subfolders]
      • • Casein Kinase 2
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGFR kinase
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • VEGFR inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Multi kinase inhibitors
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Histone deacetylase
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Janus kinase
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hMAO
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • MEK
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ASK1
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • CDKs
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Nek2/Hec1
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • PI3K
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • PDK1
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • GSK-3β
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Tyrosine kinase
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • VCP Inhibitors
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • HIF Inhibitors
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ALK5 kinase Inhibitors
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Other Protein Kinase Inhibitors
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • casein-kinase-2?format=feed&type=rss
        • egfr-kinase?format=feed&type=rss
        • vegfr-inhibitor?format=feed&type=rss
        • multi-kinase-inhibitors?format=feed&type=rss
        • histone-deacetylase?format=feed&type=rss
        • janus-kinase?format=feed&type=rss
        • hmao?format=feed&type=rss
        • mek?format=feed&type=rss
        • ask1?format=feed&type=rss
        • cdks?format=feed&type=rss
        • nek2-hec1?format=feed&type=rss
        • pi3k?format=feed&type=rss
        • pdk1?format=feed&type=rss
        • gsk-3?format=feed&type=rss
        • tyrosine-kinase?format=feed&type=rss
        • vcp?format=feed&type=rss
        • hif?format=feed&type=rss
        • alk5-kinase?format=feed&type=rss
        • other?format=feed&type=rss
        • Other Protein Kinase Inhibitors
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • • casein-kinase-2/13 pages
        • • 7015980251
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156728
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7013050095
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1655044
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1298046
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1655047
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156732
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1234350
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1436838
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020402316
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0107830116
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0107830108
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0107830107
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • egfr-kinase/15 pages
        • • 7070707144
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0116690044
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0107930017
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440152
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440170
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440173
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440177
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440188
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7011830583
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7015070078
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7017500001
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7017500002
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7017500003
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020540007
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020540711
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • vegfr-inhibitor/9 pages
        • • 7015070102
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707144
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707143
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156353
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156360
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156358
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707147
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156354
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156355
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • multi-kinase-inhibitors/10 pages
        • • 3476873
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707024
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0117392020
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7119860038
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7015070102
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707143
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156353
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156360
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156355
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707144
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • histone-deacetylase/5 pages
        • • 7070707144
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707016
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707090
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707091
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707089
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • janus-kinase/6 pages
        • • 7015070102
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 6543537
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707149
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707069
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707057
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7015070103
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hmao/11 pages
        • • 5030790694
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0115540178
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0115540179
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0115540181
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0115540186
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0115540187
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0105860050
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7210430507
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7012702160
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7113231449
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7119860038
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • mek/3 pages
        • • 7070707062
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707138
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1183194
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ask1/5 pages
        • • 7119152011
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7216540395
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7216540398
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7216540347
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7214191049
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • cdks/6 pages
        • • 3485491
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707137
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707068
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707035
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020402317
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1112092
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • nek2-hec1/3 pages
        • • 7070707072
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707071
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707073
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • pi3k/5 pages
        • • 7070707142
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707058
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707046
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707047
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707028
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • pdk1/4 pages
        • • 7070707060
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707053
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707045
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707044
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • gsk-3/4 pages
        • • 7070707084
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707013
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707151
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707150
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • tyrosine-kinase/6 pages
        • • 7070707056
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707049
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707059
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0117391283
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7119681298
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707032
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • vcp/2 pages
        • • 7211760421
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7211760110
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hif/2 pages
        • • 7559293
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707015
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • alk5-kinase/2 pages
        • • 7070707105
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707106
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • other/36 pages
        • • 3709336
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 3703212
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1736860
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7139318
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7119987003
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7110940341
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707121
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020160376
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7012180041
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 11639280
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0129720278
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0111070275
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 3463893
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1458183
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1394993
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 3476873
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0114360035
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0123300047
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707021
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707012
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707011
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1183326
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707029
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0127441873
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707140
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7112880116
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7216513379
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1055516
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707145
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707133
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707132
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707001
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020540496
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020402324
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020402323
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0129720262
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • cell-signaling/16 pages [+52 in 8 subfolders]
      • • Ion channel
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Hedgehog SP Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • mTOR pathway
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ROCK signaling
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Growth Factor Receptor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Agonists
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Antagonist
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Other Cell Signaling
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ion-channel?format=feed&type=rss
        • hedgehog-sp-inhibitor?format=feed&type=rss
        • mtor-pathway?format=feed&type=rss
        • rock-signaling?format=feed&type=rss
        • growth-factor-receptors?format=feed&type=rss
        • agonists?format=feed&type=rss
        • antagonist?format=feed&type=rss
        • other-cell-signaling?format=feed&type=rss
      • • ion-channel/3 pages
        • • 0111850003
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1869197
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0129690030
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hedgehog-sp-inhibitor/4 pages
        • • 7070707159
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707158
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156359
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7211760148
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • mtor-pathway/4 pages
        • • 7010010139
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707148
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707024
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707142
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • rock-signaling/2 pages
        • • 7070707146
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707131
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • growth-factor-receptors/23 pages
        • • 7015070102
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707143
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156353
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156360
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156358
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707147
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156354
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156355
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707144
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0116690044
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0107930017
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440152
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440170
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440173
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440177
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0108440188
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7011830583
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7015070078
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7017500001
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7017500002
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7017500003
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020540007
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7020540711
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • agonists/5 pages
        • • 0127440673
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7211760086
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7114471128
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707134
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707030
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • antagonist/7 pages
        • • 1156355
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1156359
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707164
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 15380609
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 1024331
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707014
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7070707009
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • other-cell-signaling/4 pages
        • • 0117890066
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 7139318
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 11639280
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • 0129720278
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • stem-cell-research/4 pages
      • • 7010010139
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • 7070707017
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • 7070707013
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • 7070707131
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • metabolism-metabolite/4 pages
      • • 0103370265
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • 3699690
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • 7070707027
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • 0127440673
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • various-inhibitors/53 pages
      • • New potent and selective inhibitor of CK2
          New potent and selective inhibitor of CK2 (casein kinase 2) with IC50 = 0.125 μM, available exclusively from OTAVAchemicals.
        • New potent and selective inhibitor of CK2 (casein kinase 2)
          New potent and selective inhibitor of CK2 (casein kinase 2) with IC50 = 0.1 μM, Ki=40 nM available exclusively from OTAVAchemicals.
        • Inhibitor of protein kinase CK2 (FNH68)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of protein kinase CK2 (FNH79)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of protein kinase CK2 (FLC21)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of protein kinase CK2 (FLC26)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of protein kinase CK2 (NHTP23)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of protein kinase CK2 (NHTP33)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of EGFR
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGFR (HER-1 in humans) Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGFR (HER1 in humans) Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGF-R erbB1 Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGFR (HER1) Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ErbB1 (EGFR) Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGFR (ErbB1) Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • HER1 in humans Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ErbB-1 Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGFR Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Epidermal growth factor receptor erbB-1 Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • EGFR erbB1 Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Epidermal growth factor receptor erbB1 Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • VEGFR Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Selective JAK3 inhibitor (TCS 21311)
          Potent JAK3 inhibitor (IC50 = 8 nM). Selective for JAK3 over JAK1, JAK2 and TYK2.
        • Inhibitor of monoamine oxidase (MAO) and aldehyde dehydrogenase (ALDH-2)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of MAO-A and MAO-B
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • MAO-B and MAO-A Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • MAO-A/MAO-B Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hMAO-B and hMAO-A Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hMAO-A/hMAO-B Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hMAO-A and hMAO-B Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • MAO-B/MAO-A Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hMAO-B Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Monoamine oxidase B Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • hMAO-B Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • New inhibitor of human protein kinase ASK1 (MAP3K5, MAPKKK5, MEKK5)
          New potent and selective inhibitor of ASK1 with IC50 = 3 μM, Ki=500 nM available exclusively from OTAVAchemicals.
        • PFTA25, inhibitor of apoptosis signal-regulating kinase 1 (ASK1)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • PFTA26, inhibitor of apoptosis signal-regulating kinase 1 (ASK1)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • PFTA13, inhibitor of apoptosis signal-regulating kinase 1 (ASK1)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • PFTA32, inhibitor of apoptosis signal-regulating kinase 1 (ASK1)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • K-604 is a selective ACAT-1 inhibitor
          K-604 is a selective ACAT-1 inhibitor
        • Nitric oxide synthase (inducible) Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Beta amyloid A4 protein Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Kinesin-like protein 1 Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of valosin-containing protein (VCP)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of valosin-containing protein (VCP or p97)
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Carbonic anhydrase IX Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • ROCK Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • mTOR inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of Hepatitis C virus NS3 protease/helicase
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Hepatitis C virus NS3 protease/helicase inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Inhibitor of Tyrosine-protein kinase ABL
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Tyrosine-protein kinase ABL Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
        • Serine/threonine-proteine kinase PIM1/PIM2 Inhibitor
          Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • screening-compounds-for-agrochemical-discovery/4 pages
    • • Herbicides-Like Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Insecticides-Like Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Fungicides-Like Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • nAChR Targeted Library
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • about/3 pages
  • • Overview
      OTAVAchemicals is an international science-based chemical company ???? specialize in the development and production of featured chemicals, bio-chemicals and bioanalytical reagents.
    • Customers
      Pharmaceutical and biotechnology companies what collaborates with OTAVAchemicals
    • Product Spotlights
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • services/8 pages [+10 in 1 subfolder]
  • • Custom Synthesis
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Chemical Route Optimization and Scale Up Synthesis
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Synthetically Accessible Virtual Inventory (SAVI)
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Molecular Modeling and Lead Discovery
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Bioinformatics Services
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Contract Research
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Chemical Optimization
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • chemical-optimization?format=feed&type=rss
  • • chemical-optimization/10 pages
    • • Synthesis and optimization of novel X-165 inhibitor analogues with potent bioactivity to the enzyme autotaxin
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Quinolinones as Inhibitors of mIDH1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Arylpyridazines as Inhibitors of p38αMAPK
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Pyrazolo[3,4-d]pyrimidines as Dual-targeted Inhibitors of HDAC1 and mTOR
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of 1-(Aryl-1H-pyrrolyl)(phenyl)methyl-1H-imidazole Derivatives as Antiprotozoal Agents
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Arylpiperazines as Perspective Toxoplasma gondii Dihydrofolate Reductase Inhibitors
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Styryl-phenyl-ureas as Dual-targeted Inhibitors of PD-L1 and VEGFR-2
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Novel Derivatives of NMDARs Allosteric Modulators
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Tetrahydroisoquinoline Derivatives as Perspective Inhibitors of P-glycoprotein 1
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Synthesis of Barbadin Analogs as Perspective Inhibitors of the ß-Arrestin/ß2-Adaptin Interaction
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • targets/45 pages [+1 in 1 subfolder]
  • • SH2 Domain Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Catechol O‑Methyl Transferase Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • EZH2 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • S1PR1 Targeted Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • RAR-related Orphan Receptor-γ Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • MMP2 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • SARMs-Like Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Viral RNA-dependent RNA Polymerases Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • PDZ Domain Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • GASC1 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Cathepsin K Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Renin Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Kallikrein 6 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Caspase 2 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • GABA Receptors Targeted Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • SERMs-Like Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • ß-Arrestin/ß2-Adaptin Interaction Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Transporter Targeted Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Nuclear ER Targeted Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • ERR Gamma Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • AD Polypharmacology Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • PRMTs Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • ClpP Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • hPreP Agonist Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • PARP-1 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • 5-HT1B Receptor Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • SGLT2 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • DPP4 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • HMGCR Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • DOT1L Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • BRD4 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • HDAC Targeted Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • DNMTs Targeted Libraries
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • HATs Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • CREBBP Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Histamine Receptor Antagonist Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • HCN Channel Blocker Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Calcium Channel Blockers
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Voltage-Gated Sodium Channel Blockers Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Potassium Channel Blockers
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • GCR Antagonist Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Liver X Receptor Beta Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • 11β-HSD1 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Hsp90 Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • p38 MAP Kinase Alpha Targeted Library
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • • kallikrein-6-targeted-library/1 page
    • • Drug-Like Green collection
        The Green Collection compound library (more than 37,000 compounds total) was prepared on the basis of In-house Stock library and pre-formatted by Lipinsky “rules of five”
  • research/6 pages
  • • Current Research
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Seed Innovation Discovery Program (SIDP)
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Research Collaboration
      OTAVAchemicals contract research projects from 2000 year
    • Publications
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Careers
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • Our products are a part of Sigma-Aldrich
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • ordering/2 pages [+1 in 1 subfolder]
  • • Order Process
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • General Terms and Conditions of Sale for OTAVAchemicals
      Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • • order-process/1 page
    • • Serine/threonine-proteine kinase PIM1/PIM2 Inhibitor
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • files/ [91 in 2 subfolders]
  • • newsletters/90 pages
    • • 1_Large_Collection_of_Focused_Libraries.pdf
      • 2_Protein-Protein_Interaction_Focused_libraries.pdf
      • 3_5-HT1B_Receptor_Antagonists.pdf
      • 4_Beta-Turn_Peptidomimetic_Library.pdf
      • 5_DOT1L_Targeted_Library.pdf
      • 6_Bromodomain-containing_Protein_4_(BRD4)_Targeted_Library.pdf
      • 7_19F_NMR_Fluorine-containing_Fragment_Library.pdf
      • 8_Tangible_Screening_Compounds_Collection.pdf
      • 9_Histone_Deacetylase_Targeted_Libraries.pdf
      • 10_Tangible_Chemical_Building_Blocks_Collection.pdf
      • 11_2014_Update_of_Fragment_Library.pdf
      • 12_2014_Spotlight_Novel_Off-the-shelf_Unnatural_Amino_Acids.pdf
      • 13_DNMT1_and_DNMT3b_Targeted_Libraries.pdf
      • 14_2014_Spotlight_Novel_Off-the-shelf_Carboxylic_Acids.pdf
      • 15_Liver_X_Receptor_Beta_Targeted_Library.pdf
      • 16_2014_Spotlight_Novel_Off-the-shelf_Aliphatic_Primary_Amines.pdf
      • 17_Chelator_Fragment_Library.pdf
      • 18_2014_Spotlight_Novel_Off-the-shelf_Aldehydes.pdf
      • 19_Histone_Acetyltransferase_Targeted_Library.pdf
      • 20_2014_Spotlight_Novel_Off-the-shelf_Morpholines.pdf
      • 21_2014_Spotlight_Novel_Off-the-shelf_Pyridines.pdf
      • 22_Design_Your_Targeted_Library_with_us.pdf
      • 23_2014_Spotlight_Novel_Off-the-shelf_Piperidines.pdf
      • 24_Synthesize_Your_Structure_with_us.pdf
      • 25_Halogen-Enriched_Fragment_Library.pdf
      • 26_2014_Spotlight_Novel_Off-the-shelf_Pyrazoles.pdf
      • 27_2014_Spotlight_Novel_Off-the-shelf_Carboxylic_Acids.pdf
      • 28_2014_Spotlight_Best-Selling_Compounds.pdf
      • 29_2014_voltage-gated_sodium_channel_blockers_library.pdf
      • 30_2014_Spotlight_Novel_Off-the-shelf_derivatives_of_pyrrolidines.pdf
      • 31_CREB_Binding_Protein_(CREBBP)_Targeted_Library.pdf
      • 32_2014_Spotlight_Novel_Off-the-shelf_cyclobutane_derivatives.pdf
      • 33_New_Update_of_Fragment_Library_Oct_2014.pdf
      • 34_2014_Spotlight_Novel_Off-the-shelf_indole_derivatives.pdf
      • 35_11b_Hydroxysteroid_Dehydrogenase_Type_I_Targeted_Library.pdf
      • 36_2014_Spotlight_novel_off-the-shelf_derivatives_of_thiophenes.pdf
      • 37_2014_Spotlight_novel_off-the-shelf_derivatives_of_pyrimidines.pdf
      • 38_Solubility_Fragment_Library.pdf
      • 39_2014_Spotlight_Novel_Off-the-shelf_derivatives_of_Piperazines.pdf
      • 40_Histamine_Receptor_Antagonist_Targeted_Library.pdf
      • 41_Kv15_Potassium_Channel_Blockers.pdf
      • 42_2015_Spotlight_Novel_Off-the-shelf_derivatives_of_Sulfonyl_chlorides.pdf
      • 43_2015_Spotlight_Novel_Off-the-shelf_Aliphatic_Primary_Amines.pdf
      • 44_Calcium_Channel_Blockers.pdf
      • 45_2015_Spotlight_Novel_Off-the-shelf_derivatives_of_Piperidines.pdf
      • 46_Heat_Shock_Protein_9_(Hsp90)_Targeted_Library.pdf
      • 47_2016_Spotlight_Best_Selling_Compounds.pdf
      • 48_Dipeptidyl_Peptidase-4_(DPP4)_Library.pdf
      • 49_Glucocorticoid_Receptor_Antagonist_Library.pdf
      • 50_HCN_Channel_Blocker_Library.pdf
      • 51_HMG-CoA_Reductase_Targeted_Library.pdf
      • 52_Sodium_Glucose_Cotransporter_2_Targeted_Library.pdf
      • 53_Poly_(ADP-Ribose)_Polymerase-1_(PARP-1).pdf
      • 54_Screening_Collection.pdf
      • 55_Human_Presequence_Protease_Agonists.pdf
      • 56_2016_Innovative_Chemical_Building_Blocks.pdf
      • 57_Phenotypic_Screening_Library.pdf
      • 58_RNA_Targeted_Library.pdf
      • 59_Protein_Arginine_Methyltransferases_Targeted_Library.pdf
      • 60_2017-Spotlight_Recently_Synthesized_Chemical_Building_Blocks.pdf
      • 61_SH2_Domain_Targeted_Library.pdf
      • 62_2017_Spotlight_RECENTLY_SYNTHESIZED_INDOLE_2_CARBOXYLIC_ACIDS.pdf
      • 63_Estrogen_Related_Receptor_Gamma_Targeted_Library.pdf
      • 64_AD-Targeted-Polypharmacology-Library.pdf
      • 65_Caspase-2-Targeted-Library.pdf
      • 66_2017_04_Screening_Collection.pdf
      • 67_Nuclear_Estrogen_Receptor_Targeted_Libraries.pdf
      • 68_2017_05_Screening_Collection.pdf
      • 69_2017_Spotlight_RECENTLY_SYNTHESIZED_SPIRO_COMPOUNDS.pdf
      • 70_New_Analogs_of_Barbadin_as_Perspective_Inhibitors_of_the_Beta_Arrestin_Beta_2_Adaptin_Interaction.pdf
      • 71_New_Analogues_of_Substituted_Pyrazoles_as_Anti_Mycobacterial_Agents.pdf
      • 72_Transporter_Targeted_Libraries.pdf
      • 73_2017_Spotlight_NEWLY_SYNTHESIZED_QUATERNARY_AMMONIUM_SALTS.pdf
      • 74_b-Arrestin_b2-Adaptin_Interaction_Targeted_Library.pdf
      • 75_Synthesis_of_the_New_Analogs_of_2_6-Naphthyridine_as_Perspective_Inhibitors_of_Protein_Kinase_D.pdf
      • 76_Selective_Estrogen_Receptor_Modulators-Like_Library.pdf
      • 77_Screening_Compounds_for_Agrochemical_Discovery.pdf
      • 78_2017_11_Updated_of_Databases.pdf
      • 79_GABA_Receptors_Targeted_Libraries.pdf
      • 80_2017_Spotlight_Novel_Recently_Synthesized_2_3_4_5-Tetrahydro-1H-Benzo[b]azepine-2-Carboxylic_Acid_and_its_t-Bu_Ester.pdf
      • 81_Selective_Androgen_Receptor_Modulators-Like_Library.pdf
      • 82_Updated_Natural_Product-Like_Library.pdf
      • 83_Nicotinic_Acetylcholine_Receptor_Targeted_Library.pdf
      • 84_Updated_b-Turn_Peptidomimetic_Library.pdf
      • 85_Synthesis_of_Novel_Chemical_Building_Blocks.pdf
      • 86_2018_03_Updated_Screening_Collection.pdf
      • 87_Matrix_Metalloproteinase-2_Targeted_Library.pdf
      • 88_Updated_a-Helix_Peptidomimetic_Library.pdf
      • 89_Kallikrein_6_Targeted_Library.pdf
      • 90_RAR-related_Orphan_Receptor-y_Targeted_Library.pdf
    • noteworthy_compounds/1 page
    • • OTAVAchemicals_bioactive_small_molecules_2014.pdf
  • jsme/1 page
  • • JSME demo page
  • component/ [7 in 2 subfolders]
  • • user/3 pages
    • • Registration
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Forgot your Password?
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Forgot your Username?
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
    • content/2 pages [+2 in 1 subfolder]
    • • Various inhibitors and other biologically active compounds
        OTAVAchemicals offers a number of inhibitors, activators and other biologically active compounds modulating activity of distinct targets. These compounds are available in milligram and gram quantities. Custom and bulk quotes are also available.
      • Contact info
        OTAVAchemicals contact information http://www.otavachemicals.com
    • • article/ [2 in 1 subfolder]
      • • 75-otava-frontpage/2 pages
        • • Inhibitors
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
          • Catalogs & Booklets
            Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
  • Booklet/2 pages
  • • Seed_Innovation_Discovery_Program_SIDP.pdf
    • OTAVAchemicals_products_and_services_booklet_2018.pdf
  • home/ [2 in 1 subfolder]
  • • 75-otava-frontpage/2 pages
    • • Inhibitors
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery
      • Catalogs & Booklets
        Otava, Ltd. - synthetic organic compounds and chemical building blocks for research and drug discovery

Page created with PRO-Sitemaps.com - PRO Sitemap Service